Advanced search
Publication Cover
International Journal of Psychiatry in Clinical Practice Volume 6, 2002 - Issue 3
Submit an article Journal homepage
25
Views
14
CrossRef citations to date
0
Altmetric
Research Article

A three-year naturalistic follow-up of patients receiving clozapine: Report from India

Shrikant Srivastava
,
Ak Agarwal
&
Mukul Sharma
Pages 167-171 | Published online: 12 Jul 2009

  • Clozapine Study Group (1993) The safety and efficacy of clozapine in severe treatment-resistant schizophrenic patients in the UK. Br J Psychiatry 35: 8-15.
  • Rosenheck R, Dunn L, Peszke M et al (1999) Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Am J Psychiatry 156: 88-93.
  • Wahlbeck K, Cheine M, Essali A et al (1999) Evidence of clozapine effectiveness in schizophrenia: A systematic review and meta-analysis of randomized trials. Am J Psychiatry 156: 990-99.
  • Juul Povlsen U, Noring U, Fog R, Gerlach J (1985) Tolerability and therapeutic effect of clozapine: a retrospective investigation of 216 patients treated with clozapine for up to 12 years. Acta Psychiatr Scand 71: 176-85.
  • Lindstrom LH (1988) The effect of long-term treatment of clozapine in schizophrenia: a retrospective study of 96 patients treated with clozapine for up to 13 years. Acta Psychiatr Scand 77: 524-29.
  • Lieberman JA, Safferman AZ, Pollack S et al (1994) Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry 151: 1744-52.
  • Janet T, Peter J (1998) Does participation in psychosocial treatment augment the benefit of clozapine? Acta Psychiatr Scand 55: 618-25.
  • World Health Organization (1992) The ICD-I0 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. WHO, Geneva
  • Agarwal AK, Sharma M, Srivastava S et al (1997) An open clinical trial with clozapine in treatment-resistant schizophrenics. Indian J Psychiatry 39: 70-75.
  • Overall JE, Gorham DR (1960) The Brief Psychiatric Rating Scale. Psychol Rep. 10: 791- 812.
  • Kay SG, Opier LD, Lindenmayer JR (1988) Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenia. Psychiatry Res 23: 91-110.
  • Buchanan RW, Carpenter Jr WT (2000) Schizophrenia: Introduction and overview. In: Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry (7th edn) 1096-1109. Lippincott, Williams & Wilkins, Philadelphia.
  • Liebrman JA (1999) Pathophysiologic mechanism in thepathogenesis and clinical course of schizophrenia. J Clin Psych 60(Suppl l2):9-12.
  • Kane JM, Honigfeld G, Singer J et al (1988) Clozapine for the treatment-resistant schizophrenics. A double blind comparison with chlorpromazine. Arch Gen Psychiatr 45: 789-96.
  • Essock SM, Hargreaves WA, Dohm F et al (1996) Clozapine eligibility among state hospital patients. Schizophr Bull 22: 1525.
  • Conley RR, Carpenter WT, Tamminga CA (1997) Time to clozapine in a standardized trial. Am J Psychiatry. 154: 124347.
  • Buchanan RW, Breier A, Kirkpatrick B et al (1998) Positive and negative symptom response to clozapine in schizophrenic patients with and without deficit syndrome. Am J Psychiatry 155: 751-60.
  • Hasegawa M, Gutierrez-Esteinou R, Way L et al (1993)Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking. Psychopharmacology (Berl.) 13: 383-90.
  • Kronig MH, Munne RA, Szymanski S (1995) Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients. Am J Psychiatry 152: 179-82.
  • Vanderzwagg C, McGee M McEvoyJP et al (1996) Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges. Amn J Psychiatry 153:1579-84.
  • Fleishhakker WW, Hummer M, Kurz M et al (1994) Clozapine dose in the United States and Europe: implications for therapeutic and adverse effects. J Clin Psychiatry 55: (Suppl 3): 78-81.
  • World Health Organization (1973) Report of the International Pilot Study of Schizophrenia (Vol. 1). WHO, Geneva.
  • Leff J, Sartorius N, Jablensky A et al (1992) The International Pilot Study of Schizophrenia: five-year follow-up findings. Psychol Med 22: 131- 45.
  • Sartorius N, Jablensky A, Korten A et al (1986) Earlymanifestations and contact incidence of schizophrenia Psychol Med 16: 909-28.
  • Matsuda KT, Cho MC, Lin KM et al (1996) Clozapine dosage, serum levels, efficacy and side effect profiles: a comparison of Korean-American and Caucasian patients. Psychopharmacol Bull 32: 253-7.
  • Ramirez LF (1996) Ethnicity and psychopharmacology in Latin America. Mt Sinai J Med (Ny) 63: 330-1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.